Systemic treatments with tyrosine kinase inhibitors and platinum-based chemotherapy in patients with unresectable or metastatic hepato-cholangiocarcinoma

JOURNAL OF HEPATOLOGY（2022）

引用 6|浏览30

暂无评分

摘要

First-line systemic treatments with TKIs or platinum-based chemotherapies have similar efficacy in patients with unresectable/metastatic cHCC-CCA. The ALBI score predicts OS.

查看译文

关键词

Hepatocholangiocarcinoma,Cholangiocarcinoma,Hepatocellular carcinoma,Systemic treatment,Platinum,Tyrosine kinase inhibitors

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要